Protuoso Biosciences
PrivateLast Round
Seed
May 27, 2026
Total Funding Raised
$19M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Protuoso Biosciences is a biotechnology company that develops a protein synthetic biology platform to create multifunctional biologics for complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protuoso Biosciences Comparables
Compare Protuoso Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evozyne | 77% | |
| LabGenius Therapeutics | 77% | |
| BigHat Biosciences | 77% |
Protuoso Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 27, 2026 | ||||
| Seed | May 27, 2026 |
Protuoso Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Darwin Venture Management | Seed |
| NSG Ventures | Seed |
| Darwin Ventures | Seed |
| SEEDS Capital | Seed |
| Darwin Ventures | Seed |
| TA YA VENTURE HOLDINGS LIMITED | Seed |
| SEEDS Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$9.5M round led by TA YA VENTURE HOLDINGS LIMITED and Darwin Venture Management.
- May 27, 2026
$9.5M round led by Taya Ventures and Darwin Ventures.
Recent news
Latest coverage and updates
- is_developingAug 14, 2026
Protuoso is developing modular biologics that target multi-pathway diseases on Aug 14th '26.
Protuoso Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Protuoso Biosciences's valuation, stock price, and market status.
Is Protuoso Biosciences a public or private company?
Protuoso Biosciences is a private company.
What is the current stock price of Protuoso Biosciences?
Protuoso Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Protuoso Biosciences worth (valuation)?
Valuation information for Protuoso Biosciences is not publicly available.
Can I buy Protuoso Biosciences stock?
Protuoso Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Protuoso Biosciences's last funding round?
Protuoso Biosciences's most recent funding round was Seed on May 27, 2026.
Who are the main investors in Protuoso Biosciences?
Key investors in Protuoso Biosciences include Darwin Venture Management, Darwin Ventures, Darwin Ventures, TA YA VENTURE HOLDINGS LIMITED, Taya Ventures.
Will Protuoso Biosciences IPO soon?
No public IPO plans have been announced for Protuoso Biosciences.
How can I track Protuoso Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Protuoso Biosciences's secondary market activity and sign up for updates.